Stock IQMD INTELLIGENT MEDICINE ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Intelligent Medicine Acquisition Corp.

Equities

IQMD

US45828D1063

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
INTELLIGENT MEDICINE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
BU
Intelligent Medicine Acquisition Corp.(NasdaqGM:IQMD) dropped from NASDAQ Composite Index
CI
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Intelligent Medicine Acquisition Corp. Auditor Raises 'Going Concern' Doubt
CI
INTELLIGENT MEDICINE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
AQ
INTELLIGENT MEDICINE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
AQ
INTELLIGENT MEDICINE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
INTELLIGENT MEDICINE ACQUISITION CORP. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
INTELLIGENT MEDICINE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders
BU
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Certain Class B Common Stock of Intelligent Medicine Acquisition Corp. are subject to a Lock-Up Agreement Ending on 3-MAY-2022.
CI
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IQMD Stock
  4. News Intelligent Medicine Acquisition Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW